# Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

> **NCT02729116** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Khon Kaen University** · enrollment: 30 (estimated)

## Conditions studied

- Anti-Infective Agents, Urinary
- Escherichia Coli Infections
- Klebsiella Infections
- Kidney Transplantation
- Urinary Tract Infections

## Interventions

- **DRUG:** Sitafloxacin
- **DRUG:** Ertapenem

## Key facts

- **NCT ID:** NCT02729116
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2023-12
- **Final completion:** 2024-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729116, "Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT02729116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*